IMAGE: INVESTIGATOR AT JOSLIN DIABETES CENTER AND ASSOCIATE PROFESSOR AT HARVARD MEDICAL SCHOOL view more CREDIT: JOHN SOARES SGLT-2 inhibitors are a relatively new class of diabetes drugs that have shown many benefits for people with type 2 diabetes who have not responded well to previous interventions, including diet changes and metformin. Patients who take this medication see...